Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-07-24
1997-05-13
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 56, A61K 3800, A61K 31725
Patent
active
056292848
ABSTRACT:
A method for treating retinal diseases includes administering an effective amount of midkine to patients suffering from retinal diseases. The method of the invention is effective in ameliorating optical disorders of retinas and is quite safe.
REFERENCES:
patent: 3869548 (1975-03-01), Dabis
Medline Abstract 95335377 of Unoki et al., Nippon Ganka Gakkai Zasshi, 99(6), pp. 636-641 Jun. 1995.
Muramatsu, "Midkine: Growth Differentiation Factor Under Control of Retionoic Acid", The Japanese Biochemical Society, Biochemistry, vol. 66, No. 7, 1994.
Unoki et al, "The Relationship Between Retinal Degeneration of White Rats Under Light Irradiation and Midkine Which Is a Retionic Acid-Responsive Growth Factor", 14th Meeting of the Japan Eye-Pharmacological Socieity, Published Aug. 20, 1994.
Unoki et al, "Rescue of Photoreceptors from the Damaging Effects of Constant Light By Midkine, a Retionic Acid-Responsive Gene Product", Investigative Ophthalmology & Visual Science, Nov. 1994, vol. 35, No. 12.
Arimura Hitoshi
Muramatsu Hisako
Muramatsu Takashi
Ohba Norio
Okubo Akiko
Henley III Raymond
Meiji Milk Products Co. Ltd.
LandOfFree
Method for treating retinal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating retinal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating retinal diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385362